ESMO Targeted Anticancer Therapies Congress 2024
The European Society for Medical Oncology (ESMO) Targeted Anticancer Therapies Congress 2024, taking place in Paris, France, features speakers from academia and industry, as well as multiple presentations, special sessions, and poster sessions. The congress offers “participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents with a particular emphasis on early drug development,” according to ESMO.
New adverse drug reactions appeared in the updated labels of 94% of the agents evaluated.
New research highlights the importance of monitoring for interactions between oral anticancer drugs and other therapies.
Cancers of unknown primary pose a “significant challenge due to poor clinical outcomes and limited treatment options."
Researchers used a deep learning software to measure muscle, fat, subcutaneous fat, and visceral fat in 3D scans.
Advertisement
Advertisement
